MedPath

Effects of infusion of yerba mate (Ilex paraguariensis) in vascular functio

Not Applicable
Conditions
overweight
obesity
Registration Number
RBR-4x2hh8b
Lead Sponsor
niversidade Federal de Santa Catarina
Brief Summary

Cardiovascular diseases are the leading cause of death worldwide, and some nutritional factors can reduce their incidence. Yerba mate (YM), a plant widely consumed as a hot or cold infusion, may improve the cardiovascular system considering its composition and antioxidant and anti-inflammatory properties. However, the effects of YM on cardiovascular parameters, such as endothelial function, still need to be fully understood. Therefore, this study aimed to evaluate the impact of the acute ingestion of YM infusion (hot or cold) on endothelial function, central hemodynamic (heart), and autonomic modulation of the heart. In this crossover randomized clinical trial, 13 participants (18-40 years old) of both sex were evaluated in three conditions: control (water), cold YM infusion, and hot YM infusion. The primary outcome was endothelial function through flow-mediated dilation (FMD), and secondary outcomes included blood pressure (BP), heart rate (HR) and through heart rate variability (HRV). Parameters were evaluated before and after (40 and 80 minutes) intervention. The analysis of variance (ANOVA) showed an intervention effect in the FMD(%) (p<0.05), with cold and hot YM being related to higher FMD% than controls. However, no time or time*intervention effects were found. ANOVA showed a time effect on BP, HR, and HRV time and frequency domains variables (p<0.05), although no time*intervention or intervention effect was observed. These data indicate no relevant impact of YM infusion on endothelial function, central hemodynamic and autonomic parameters in healthy, young volunteers, whilst this effect was not altered by the temperature of YM. Further studies are needed to understand the potential effects of YM.

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruitment completed
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

Adults of both sexes aged between 18 and 40 years old

Exclusion Criteria

Smokers; individuals with cardiometabolic diseases; use of medications and supplements; with the presence of an injury in the arm

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath